| 产品名称 | Laquinimod - ABR 215062 |
| 产品货号 | Axon 1970 CAS [248281-84-7] MF C19H17ClN2O3MW 356.80 Purity: 99% Soluble in DMSO Description A selective autoimmune suppressant investigated as an oral treatment for multiple sclerosis (MS) and other autoimmune diseases; Immunomodulator References Certificates Categories Extra info G Comi et al. Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 2008, 371(9630), 2085-2092. JS Yang et al. Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-β in Lewis rats. J. Neuroimmunol. 2004, 156(1–2), 3–9. Certificate of Analysis Material Safety Data Sheet Immunology Miscellaneous Immunomodulator Selective autoimmune suppressant; Immunomodulator Chemical name 5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide Parent CAS No. [248281-84-7] Order Size Unit Price Stock 10 mg €95.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
Laquinimod - ABR 215062Axon 1970 CAS [248281-84-7] MF C19H17ClN2O3
Description
A selective autoimmune suppressant investigated as an oral treatment for multiple sclerosis (MS) and other autoimmune diseases; Immunomodulator
Selective autoimmune suppressant; Immunomodulator
Chemical name5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide Parent CAS No.[248281-84-7] |
| 产品资料 |
